Company Name: |
Shanghai Chaolan Chemical Technology Center
|
Tel: |
QQ:65489617 15618227136 |
Email: |
info@SuperLan-chem.com |
Products Intro: |
Product Name:OSBPL7-IN-1 CAS:1269826-44-9 Purity:98% Package:5MG;10MG;50MG;100MG,1G,5G,100G
|
|
| 3-Pyridinecarboxamide, 5-(3,4-dichlorophenyl)-N-[(1R,2R)-2-hydroxycyclohexyl]-6-(2,2,2-trifluoroethoxy)- Basic information |
Product Name: | 3-Pyridinecarboxamide, 5-(3,4-dichlorophenyl)-N-[(1R,2R)-2-hydroxycyclohexyl]-6-(2,2,2-trifluoroethoxy)- | Synonyms: | 3-Pyridinecarboxamide, 5-(3,4-dichlorophenyl)-N-[(1R,2R)-2-hydroxycyclohexyl]-6-(2,2,2-trifluoroethoxy)-;OSBPL7-IN-1;OSBPL7,orally active,ABCA1,OSBPL7 IN 1,Inhibitor,OSBPL-7-IN-1,OSBPL7IN1,inhibit;ABCA1 inducer compound G | CAS: | 1269826-44-9 | MF: | C20H19Cl2F3N2O3 | MW: | 463.28 | EINECS: | | Product Categories: | | Mol File: | 1269826-44-9.mol | |
| 3-Pyridinecarboxamide, 5-(3,4-dichlorophenyl)-N-[(1R,2R)-2-hydroxycyclohexyl]-6-(2,2,2-trifluoroethoxy)- Chemical Properties |
Boiling point | 540.9±50.0 °C(Predicted) | density | 1.46±0.1 g/cm3(Predicted) | storage temp. | Store at -20°C | form | Solid | pka | 5.98±0.40(Predicted) | color | White to off-white |
| 3-Pyridinecarboxamide, 5-(3,4-dichlorophenyl)-N-[(1R,2R)-2-hydroxycyclohexyl]-6-(2,2,2-trifluoroethoxy)- Usage And Synthesis |
Biological Activity | OSBPL7-IN-1 is an orally active oxysterol binding protein like 7 (OSBPL7) inhibitor. OSBPL7-IN-1 promotes an increase of ABCA1 at the plasma membrane without affecting mRNA expression[1].
OSBPL7-IN-1 (compound G or Cpd G; 1-10 μM) increase plasma membrane ATP-binding cassette transporter (ABCA1) in cultured human podocytes, and significantly increase ABCA1-dependent cholesterol efflux[1].
OSBPL7-IN-1 (100 mg/kg; oral gavage; daily; for 28 days) treatment normalizes proteinuria and prevents renal function decline in mouse models of proteinuric kidney disease[1]. | References | [1]. Matthew B Wright, et al. Compounds targeting OSBPL7 increase ABCA1-dependent cholesterol efflux preserving kidney function in two models of kidney disease. Nat Commun. 2021 Aug 2;12(1):4662. |
| 3-Pyridinecarboxamide, 5-(3,4-dichlorophenyl)-N-[(1R,2R)-2-hydroxycyclohexyl]-6-(2,2,2-trifluoroethoxy)- Preparation Products And Raw materials |
|